Dr. Daniel D. Von Hoff, who has been instrumental in developing numerous new cancer treatments, is among this year’s recipients of the Award of Excellence from the Hope Funds for Cancer Research.Continue reading
Tag Archives: Dan Von Hoff
TGen-Scottsdale Healthcare research shows ability to do whole genome and whole transcriptome sequencing for patients with advanced cancers
Faster analysis of genetic variations should uncover new drug targets and pathways even as cancers mutate beyond initial therapiesContinue reading
Pancreatic cancer patient survival is ‘significantly higher’ with nab-paclitaxel, in study led by TGen and Scottsdale Healthcare
NEJM today publishes findings of international trial resulting in recent FDA approval of Abraxane (nab-paclitaxel) for patients with advanced pancreatic cancer.Continue reading
FDA approves drug tested by Scottsdale Healthcare and TGen
Abraxane now part of standard-of-care for patients with advanced pancreatic cancer, following studies at the Virginia G. Piper Cancer Center at Scottsdale Healthcare
Continue reading